No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3. Zhejiang Garden Biopharmaceutical Co.,Ltd. was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.
www.hybiotech.comNo one on the platform currently holds 300401.SZ.
No tracked institution reports a position in 300401.SZ as of their last filing.
No one on the platform has traded 300401.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 7.3% | 12.1% | 13.9% | — | — | — |
| Rev. Growth % | -0.5% | 13.4% | ||||
| Profit Margin % | 24.6% | 27.5% | 31.6% | |||
| Free Cash Flow Margin % | 9.1% | -3.6% | -3.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.7B | +28.5% | $0.80 | $0.80–$0.80 | — | 1 |
| 2027 | $2.1B | +27.5% | $1.05 | $1.05–$1.05 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300401.SZZhejiang Garden Biopharmaceutical Co.,Ltd. | $15.04 | +4.52% | $8.2B | — |
| 000597.SZNortheast Pharmaceutical Group Co., Ltd. | $4.62 | -0.00% | $6.6B | — |
| 000915.SZShandong Wit Dyne Health Co.,Ltd. | $24.25 | -0.25% | $5.7B | — |
| 002390.SZGuizhou Xinbang Pharmaceutical Co., Ltd. | $2.91 | +0.00% | $5.7B | — |
| 002437.SZHarbin Gloria Pharmaceuticals Co., Ltd | $3.39 | +1.19% | $7.6B | — |
| 300039.SZShanghai Kaibao Pharmaceutical CO.,Ltd | $5.01 | -0.20% | $5.2B | — |
| 300158.SZShanxi Zhendong Pharmaceutical Co.,Ltd | $5.01 | -0.20% | $5.0B | — |
Source: Financial Modeling Prep · peers by sector/industry